A maximum-likelihood method for global-optimization-based structure determination from powder diffraction dataMARKVARDSEN, Anders J; DAVID, William I. F; SHANKLAND, Kenneth et al.Acta crystallographica. Section A, Foundations of crystallography. 2002, Vol 58, pp 316-326, issn 0108-7673, 4Article

A systematic review of the safety profile of levetiracetam : a new antiepileptic drugFRENCH, Jacqueline; EDRICH, Pascal; CRAMER, Joyce A et al.Epilepsy research. 2001, Vol 47, Num 1-2, pp 77-90, issn 0920-1211Article

Simultaneous determination of remacemide hydrochloride and desglycinylremacemide (AR-R12495XX) in brain tissue by high-performance liquid chromatographySANTANGELI, Sarah; MCNEILL, Charles; SILLS, Graeme J et al.Journal of chromatography. B, Biomedical sciences and applications. 2000, Vol 746, Num 2, pp 325-329, issn 1387-2273Article

Differential effects of remacemide and desglycinyl-remacemide on epileptiform burst firing in the rat hippocampal sliceSANTANGELI, Sarah; SILLS, Graeme J; STONE, Trevor W et al.Neuroscience letters. 2002, Vol 321, Num 1-2, pp 33-36, issn 0304-3940Article

Evaluation of a pharmacokinetic interaction between remacemide hydrochloride and phenobarbitone in healthy malesHOOPER, W. D; EADIE, M. J; BLAKEY, G. E et al.British journal of clinical pharmacology. 2001, Vol 51, Num 3, pp 249-255, issn 0306-5251Article

Remacemide hydrochloride : A novel antiepileptic agentDAVIES, J. A.General pharmacology. 1997, Vol 28, Num 4, pp 499-502, issn 0306-3623Article

Effects of anticonvulsants in a novel operant learning paradigm in rats : comparison of remacemide hydrochloride and FPL 15896AR to other anticonvulsant agentsHUDZIK, T. J; PALMER, G. C.Epilepsy research. 1995, Vol 21, Num 3, pp 183-193, issn 0920-1211Article

Regional variations in the pharmacology of NMDA receptor channel blockers : implications for therapeutic potentialPORTER, R. H. P; GREENAMYRE, J. T.Journal of neurochemistry. 1995, Vol 64, Num 2, pp 614-623, issn 0022-3042Article

High-performance liquid chromatographic method for the simultaneous measurement of remacemide (a novel anticonvulsant and cerebroprotectant) and an active metabolite in human plasmaFLYNN, J. W; O'BRIEN, J. E.Journal of chromatography. Biomedical applications. 1992, Vol 583, Num 1, pp 91-97, issn 0378-4347Article

Safety, tolerability, and pharmacokinetics of remacemide in childrenBESAG, Frank M. C; NEWTON, Rosemary E; BLAKEY, Graham E et al.Pediatric neurology. 2001, Vol 24, Num 5, pp 352-356, issn 0887-8994Article

Prevalence of epilepsy in the People's Republic of China: A systematic reviewLIAN GU; BAOYUN LIANG; PENG WU et al.Epilepsy research. 2013, Vol 105, Num 1-2, pp 195-205, issn 0920-1211, 11 p.Article

Neuroprotective effects of lamotrigine and remacemide on excitotoxicity induced by glutamate agonists in isolated chick retinaPISANI, Francesco; PEDALE, Santa; MACAIONE, Vincenzo et al.Experimental neurology (Print). 2001, Vol 170, Num 1, pp 162-170, issn 0014-4886Article

Hydrophobic vs. hydrophilic : Ionic competition in remacemide salt structuresLEWIS, Gareth R; STEELE, Gerry; MCBRIDE, Lorraine et al.Crystal growth & design. 2005, Vol 5, Num 2, pp 427-438, issn 1528-7483, 12 p.Article

Binding of [³H]desglycinyl remacemide to rat brain membranes : association with the benzomorphan attachment site of the N-methyl-D-aspartic acid receptor channelAHMED, M. S; MATHER, A; ENNA, S. J et al.Brain research. 1999, Vol 827, Num 1-2, pp 46-50, issn 0006-8993Article

Neuroprotective effect of remacemide hydrochloride in a perforant pathway stimulation model of status epilepticus in the ratHALONEN, T; NISSINEN, J; PITKÄNEN, A et al.Epilepsy research. 1999, Vol 34, Num 2-3, pp 251-269, issn 0920-1211Article

Remacemide hydrochloride reduces cortical lesion volume following brain trauma in the ratSMITH, D. H; PERRI, B. R; RAGHUPATHI, R et al.Neuroscience letters. 1997, Vol 231, Num 3, pp 135-138, issn 0304-3940Article

A comparative study of the effects of carbamazepine and the NMDA receptor antagonist remacemide on road tracking and car-following performance in actual trafficRAMAEKERS, J. G; LAMERS, C. T. J; VERHEY, F et al.Psychopharmacologia. 2002, Vol 159, Num 2, pp 203-210, issn 0033-3158Article

A randomized, controlled trial of remacemide for motor fluctuations in Parkinson's diseaseNeurology. 2001, Vol 56, Num 4, pp 455-462, issn 0028-3878Article

A randomized, double-blind, placebo-controlled, ascending-dose tolerability and safety study of remacemide as adjuvant therapy in Parkinson's disease with response fluctuationsCLARKE, C. E; COOPER, J. A; HOLDICH, T. A. H et al.Clinical neuropharmacology. 2001, Vol 24, Num 3, pp 133-138, issn 0362-5664Article

A randomized, placebo-controlled trial of coenzyme Q₁₀ and remacemide in Huntington's diseaseNeurology. 2001, Vol 57, Num 3, pp 397-404, issn 0028-3878Article

Differential effects of two NMDA receptor antagonists on cognitive-behavioral development in nonhuman primates IPOPKE, E. J; ALLEN, R. R; PEARSON, E. C et al.Neurotoxicology and teratology. 2001, Vol 23, Num 4, pp 319-332, issn 0892-0362Article

Neuroprotection of the brain during cardiopulmonary bypass : A randomized trial of remacemide during coronary artery bypass in 171 patientsARROWSMITH, J. E; HARRISON, M. J. G; NEWMAN, S. P et al.Stroke (1970). 1998, Vol 29, Num 11, pp 2357-2362, issn 0039-2499Article

Predictors of seizure freedom after surgical management of tuberous sclerosis complex: A systematic review and meta-analysisKAI ZHANG; HU, Wen-Han; CHAO ZHANG et al.Epilepsy research. 2013, Vol 105, Num 3, pp 377-383, issn 0920-1211, 7 p.Article

Na⁺ channel effects of remacemide and desglycinyl-remacemide in rat cortical synaptosomesSANTANGELI, Sarah; SILLS, Graeme J; THOMPSON, George G et al.European journal of pharmacology. 2002, Vol 438, Num 1-2, pp 63-68, issn 0014-2999Article

Evaluation of dyskinesias in a pilot, randomized, placebo-controlled trial of remacemide in advanced Parkinson diseaseArchives of neurology (Chicago). 2001, Vol 58, Num 10, pp 1660-1668, issn 0003-9942Article